476 related articles for article (PubMed ID: 24273730)
21. Microstructural changes in the substantia nigra of asymptomatic agricultural workers.
Du G; Lewis MM; Sterling NW; Kong L; Chen H; Mailman RB; Huang X
Neurotoxicol Teratol; 2014; 41():60-4. PubMed ID: 24334261
[TBL] [Abstract][Full Text] [Related]
22. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.
Schuff N; Wu IW; Buckley S; Foster ED; Coffey CS; Gitelman DR; Mendick S; Seibyl J; Simuni T; Zhang Y; Jankovic J; Hunter C; Tanner CM; Rees L; Factor S; Berg D; Wurster I; Gauss K; Sprenger F; Seppi K; Poewe W; Mollenhauer B; Knake S; Mari Z; McCoy A; Ranola M; Marek K
Mov Disord; 2015 Dec; 30(14):1885-92. PubMed ID: 26260437
[TBL] [Abstract][Full Text] [Related]
23. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
[TBL] [Abstract][Full Text] [Related]
24. Application of high-field magnetic resonance imaging in Parkinson's disease.
Qiao PF; Shi F; Jiang MF; Gao Y; Niu GM
Exp Ther Med; 2017 May; 13(5):1665-1670. PubMed ID: 28565751
[TBL] [Abstract][Full Text] [Related]
25. Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease.
Lin CP; Knoop LEJ; Frigerio I; Bol JGJM; Rozemuller AJM; Berendse HW; Pouwels PJW; van de Berg WDJ; Jonkman LE
Mov Disord; 2023 Sep; 38(9):1655-1667. PubMed ID: 37347552
[TBL] [Abstract][Full Text] [Related]
26. Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson's Disease: A Diffusion Tensor Imaging Study.
Bergsland N; Pelizzari L; Laganá MM; Di Tella S; Rossetto F; Nemni R; Clerici M; Baglio F
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834587
[TBL] [Abstract][Full Text] [Related]
27. Combining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease.
Zhang Q; Li L; Miao B; Niu H
West Indian Med J; 2015 Dec; 64(5):480-486. PubMed ID: 27400227
[TBL] [Abstract][Full Text] [Related]
28. Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease.
Aquino D; Contarino V; Albanese A; Minati L; Farina L; Grisoli M; Romita L; Elia AE; Bruzzone MG; Chiapparini L
Neurol Sci; 2014 May; 35(5):753-8. PubMed ID: 24337946
[TBL] [Abstract][Full Text] [Related]
29. NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson's disease using convolutional neural network.
Gaurav R; Valabrègue R; Yahia-Chérif L; Mangone G; Narayanan S; Arnulf I; Vidailhet M; Corvol JC; Lehéricy S
Neuroimage Clin; 2022; 36():103250. PubMed ID: 36451356
[TBL] [Abstract][Full Text] [Related]
30. Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease.
Pelizzari L; Laganà MM; Di Tella S; Rossetto F; Bergsland N; Nemni R; Clerici M; Baglio F
Front Aging Neurosci; 2019; 11():134. PubMed ID: 31214017
[TBL] [Abstract][Full Text] [Related]
31. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.
Rajagopalan V; Pioro EP
Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412
[TBL] [Abstract][Full Text] [Related]
32. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
[TBL] [Abstract][Full Text] [Related]
33. Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
Safai A; Prasad S; Chougule T; Saini J; Pal PK; Ingalhalikar M
Hum Brain Mapp; 2020 Apr; 41(5):1323-1333. PubMed ID: 31778276
[TBL] [Abstract][Full Text] [Related]
34. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
[TBL] [Abstract][Full Text] [Related]
35. Progressive Decline in Gray and White Matter Integrity in
Taylor KI; Sambataro F; Boess F; Bertolino A; Dukart J
Front Aging Neurosci; 2018; 10():318. PubMed ID: 30349475
[No Abstract] [Full Text] [Related]
36. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
[TBL] [Abstract][Full Text] [Related]
37. A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging.
Nair SR; Tan LK; Mohd Ramli N; Lim SY; Rahmat K; Mohd Nor H
Eur Radiol; 2013 Jun; 23(6):1459-66. PubMed ID: 23300042
[TBL] [Abstract][Full Text] [Related]
38. Diffusion Tensor Imaging Reveals Deep Brain Structure Changes in Early Parkinson's Disease Patients with Various Sleep Disorders.
Jiang Y; An H; Xi Q; Yang W; Xie H; Li Y; Huang D
Brain Sci; 2022 Mar; 12(4):. PubMed ID: 35447994
[TBL] [Abstract][Full Text] [Related]
39. Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review.
Zhang Y; Burock MA
Front Neurol; 2020; 11():531993. PubMed ID: 33101169
[TBL] [Abstract][Full Text] [Related]
40. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
